The telecommunications satellite technology developer was valued at $1.4bn in a series C round backed by a Koch Industries subsidiary.

The Gilead Sciences-backed oncology drug developer will join forces with Nasdaq-listed BCTG in a reverse takeover deal.

The Kaplan-backed employee development platform operator was valued at $1.4bn in a series D round that pushed its overall equity funding near the $300m mark.

Protocol Labs, Alameda Research, CMT Digital, Mastercard, JP Morgan and UBS all backed the blockchain software producer's latest round.

GS Group’s GS Futures and GS Energy subsidiaries are both cornerstone investors for the energy technology-focused venture firm’s maiden fund, which is on its way to a $75m ceiling.

Clinton Foy has left venture firm Crosscut Ventures after almost eight years to help UTA with investment and fund tactics for its corporate venture capital unit.

Originally known as Cambridge Crops, the MIT and Tufts-linked company has added $16m to its coffers.

IU Ventures has returned for a series B round for Encamp, having previously taken part in a series A round year.

Taiho has reupped its commitment to the second fund of Remiges, which focuses on spinouts of Japanese universities.

The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.